Research ExplorerPublicationsHistologic variants of upper tract urothelial carcinoma do n...

Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.

Standard

Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy. / Xylinas, Evanguelos; Rink, Michael; Margulis, Vitaly; Karakiewicz, Pierre I; Bensalah, Karim; Shariat, Shahrokh F; Collaboration, Upper Tract Urothelial Carcinoma.

In: EUR UROL, Vol. 62, No. 1, 1, 2012, p. 25-26.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Xylinas, E, Rink, M, Margulis, V, Karakiewicz, PI, Bensalah, K, Shariat, SF & Collaboration, UTUC 2012, 'Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.', EUR UROL, vol. 62, no. 1, 1, pp. 25-26. <http://www.ncbi.nlm.nih.gov/pubmed/22537797?dopt=Citation>

APA

Xylinas, E., Rink, M., Margulis, V., Karakiewicz, P. I., Bensalah, K., Shariat, S. F., & Collaboration, U. T. U. C. (2012). Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy. EUR UROL, 62(1), 25-26. [1]. http://www.ncbi.nlm.nih.gov/pubmed/22537797?dopt=Citation

Vancouver

Xylinas E, Rink M, Margulis V, Karakiewicz PI, Bensalah K, Shariat SF et al. Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy. EUR UROL. 2012;62(1):25-26. 1.

Bibtex

@article{d3eff96a64e148829f7288d304b13260,
title = "Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.",
keywords = "Humans, Male, Aged, Female, Middle Aged, Treatment Outcome, Disease-Free Survival, Retrospective Studies, Chemotherapy, Adjuvant, Salvage Therapy, Antineoplastic Agents/therapeutic use, Nephrectomy/*methods, Carcinoma/drug therapy/*pathology/*surgery, Neoplasms, Squamous Cell/drug therapy/*pathology/*surgery, Ureter/pathology/*surgery, Urologic Neoplasms/drug therapy/*pathology/*surgery, Humans, Male, Aged, Female, Middle Aged, Treatment Outcome, Disease-Free Survival, Retrospective Studies, Chemotherapy, Adjuvant, Salvage Therapy, Antineoplastic Agents/therapeutic use, Nephrectomy/*methods, Carcinoma/drug therapy/*pathology/*surgery, Neoplasms, Squamous Cell/drug therapy/*pathology/*surgery, Ureter/pathology/*surgery, Urologic Neoplasms/drug therapy/*pathology/*surgery",
author = "Evanguelos Xylinas and Michael Rink and Vitaly Margulis and Karakiewicz, {Pierre I} and Karim Bensalah and Shariat, {Shahrokh F} and Collaboration, {Upper Tract Urothelial Carcinoma}",
year = "2012",
language = "English",
volume = "62",
pages = "25--26",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.

AU - Xylinas, Evanguelos

AU - Rink, Michael

AU - Margulis, Vitaly

AU - Karakiewicz, Pierre I

AU - Bensalah, Karim

AU - Shariat, Shahrokh F

AU - Collaboration, Upper Tract Urothelial Carcinoma

PY - 2012

Y1 - 2012

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Treatment Outcome

KW - Disease-Free Survival

KW - Retrospective Studies

KW - Chemotherapy, Adjuvant

KW - Salvage Therapy

KW - Antineoplastic Agents/therapeutic use

KW - Nephrectomy/methods

KW - Carcinoma/drug therapy/pathology/surgery

KW - Neoplasms, Squamous Cell/drug therapy/pathology/surgery

KW - Ureter/pathology/surgery

KW - Urologic Neoplasms/drug therapy/pathology/surgery

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Treatment Outcome

KW - Disease-Free Survival

KW - Retrospective Studies

KW - Chemotherapy, Adjuvant

KW - Salvage Therapy

KW - Antineoplastic Agents/therapeutic use

KW - Nephrectomy/methods

KW - Carcinoma/drug therapy/pathology/surgery

KW - Neoplasms, Squamous Cell/drug therapy/pathology/surgery

KW - Ureter/pathology/surgery

KW - Urologic Neoplasms/drug therapy/pathology/surgery

M3 - SCORING: Journal article

VL - 62

SP - 25

EP - 26

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 1

M1 - 1

ER -